GSK
GlaxoSmithKline PLC
49.50$
-1.8%
vs. previous close
Closing price · As of: Aug 14, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.3% | -1.7% | -0.7% | -20.9% | +2.4% | +31.8% | +3.6% | +1.7% | -26.1% | +35.9% | -26.0% | |
| – | -8.3% | -8.6% | -2.5% | -18.4% | -1.7% | +37.3% | +3.7% | -0.8% | -27.2% | +34.0% | -25.5% | |
| – | -3.5% | -5.8% | +6.2% | -14.7% | +15.7% | +56.0% | -14.4% | -10.0% | -23.6% | +33.9% | -32.0% | |
| – | -19.0% | -21.7% | -27.1% | -14.8% | +15.6% | +55.9% | -14.3% | -10.3% | -23.6% | +33.5% | -32.0% | |
| – | -12.9% | -2.4% | +6.8% | -24.9% | -18.7% | +61.4% | +8.9% | +6.0% | -30.7% | +35.1% | -23.3% | |
| – | +4.8% | +2.8% | +2.8% | -20.1% | -4.2% | +36.6% | +7.4% | -1.0% | -28.2% | +37.3% | -23.1% | |
| – | – | – | – | – | +3.6% | -1.0% | -0.5% | +2.2% | -0.8% | – | – | |
| – | +2.0% | +1.5% | -0.2% | -24.1% | +4.5% | +28.0% | +3.2% | +3.8% | -26.9% | +37.2% | -23.7% | |
| – | +0.8% | +5.1% | -1.2% | -23.3% | +3.4% | +35.3% | +0.4% | +7.8% | -26.4% | +43.1% | -30.2% | |
| – | +0.0% | -2.9% | -2.1% | -20.4% | +4.0% | +31.0% | +1.3% | -0.3% | -26.7% | +33.1% | -26.1% | |
| – | -1.7% | -6.7% | +2.6% | -16.6% | +1.1% | +23.9% | +3.9% | +2.9% | -25.7% | +38.5% | -27.6% | |
| – | -39.3% | -7.8% | +28.8% | -33.8% | -16.6% | +7.6% | +11.2% | +36.9% | -21.8% | +121.2% | -35.9% | |
| – | +6.2% | -8.6% | -2.5% | -20.2% | -75.9% | +464.8% | +3.9% | -22.8% | -2.0% | +23.1% | -24.6% | |
| – | -11.5% | – | – | – | +3.5% | +20.2% | -7.1% | -2.7% | -1.2% | – | – | |
| – | +6.1% | +2.8% | +3.9% | -22.9% | -2.4% | +33.7% | +10.9% | +7.3% | -24.8% | +44.0% | -25.5% | |
| – | +7.7% | +8.6% | +8.2% | -24.5% | -4.8% | +37.5% | +12.4% | +11.9% | -24.4% | +50.0% | -25.4% | |
| – | +0.1% | -0.1% | +0.2% | -1.0% | +1.6% | -0.2% | -0.7% | -0.2% | -0.4% | -0.3% | -0.3% |
Data as of: August 14, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.